tradingkey.logo
tradingkey.logo
Suchen

SNWV

SNWV
Zur Watchlist hinzufügen
10.630USD
+0.030+0.28%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
91.36MMarktkapitalisierung
5.51KGV TTM

mehr Informationen über SANUWAVE Health Inc Unternehmen

Sanuwave Health, Inc. is an ultrasound and shock wave technology company. It is a provider of wound care products. It is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. It applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, and aesthetic/cosmetic. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression technology to converge at precise selected targets to produce short duration compression burst and are used in both wound and orthopedic applications under the brand names dermaPACE and others.

SNWV Informationen

BörsenkürzelSNWV
Name des UnternehmensSANUWAVE Health Inc
IPO-datumNov 07, 2008
CEOFrank (Morgan C)
Anzahl der mitarbeiter46
WertpapierartOrdinary Share
GeschäftsjahresendeNov 07
Addresse9600 W. 6Th Sstreet
StadtEDEN PRAIRIE
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl55344
Telefon19526561029
Websitehttps://sanuwave.com/
BörsenkürzelSNWV
IPO-datumNov 07, 2008
CEOFrank (Morgan C)

Führungskräfte von SNWV

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Ian Miller
Mr. Ian Miller
Lead Independent Director
Lead Independent Director
48.43K
--
Mr. Peter Stegagno
Mr. Peter Stegagno
Chief Regulatory Officer
Chief Regulatory Officer
2.03K
--
Dr. Iulian Cioanta, Ph.D.
Dr. Iulian Cioanta, Ph.D.
Chief Science and Technology Officer
Chief Science and Technology Officer
41.00
--
Mr. Daniel Coyle
Mr. Daniel Coyle
Chief Operating Officer
Chief Operating Officer
37.00
--
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
Independent Director
Independent Director
--
-100.00%
Mr. Jim (Jim) Tyler
Mr. Jim (Jim) Tyler
Independent Director
Independent Director
--
--
Mr. Morgan C. Frank
Mr. Morgan C. Frank
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Peter Sorensen
Mr. Peter Sorensen
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Timothy Wern
Mr. Timothy Wern
Executive Vice President - Sales, U.S. Wound Business
Executive Vice President - Sales, U.S. Wound Business
--
--
Mr. Gregory (Greg) Bazar
Mr. Gregory (Greg) Bazar
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Ian Miller
Mr. Ian Miller
Lead Independent Director
Lead Independent Director
48.43K
--
Mr. Peter Stegagno
Mr. Peter Stegagno
Chief Regulatory Officer
Chief Regulatory Officer
2.03K
--
Dr. Iulian Cioanta, Ph.D.
Dr. Iulian Cioanta, Ph.D.
Chief Science and Technology Officer
Chief Science and Technology Officer
41.00
--
Mr. Daniel Coyle
Mr. Daniel Coyle
Chief Operating Officer
Chief Operating Officer
37.00
--
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
Independent Director
Independent Director
--
-100.00%
Mr. Jim (Jim) Tyler
Mr. Jim (Jim) Tyler
Independent Director
Independent Director
--
--